A multicenter randomized controlled clinical study of Yinlai Decoction in the treatment of children with influenza (pulmonary and gastric heat accumulation syndrome)

Beijing University of Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•?1 year old < age = 12 years old; ? Meet the diagnostic criteria and syndrome differentiation criteria of influenza; ? Duration of fever =48 hours; ? The informed consent process is in accordance with the provisions, and the legal representative or the subject child (=8 years old) signs the informed consent together; ? Novel coronavirus nucleic acid test was negative.

•? Diseases with conjunctival pharyngeal fever, herpetic angina, suppurative tonsillitis and novel coronavirus infection that need to be identified with influenza; ? Influenza complications such as sinusitis, otitis media, bronchitis, etc.; ? Severe or critical cases of influenza; ? Antiviral drugs have been used within 48 hours before this visit; ? Positive systemic steroid therapy or other immunosuppressive therapy; ? Have a history of epilepsy or high fever convulsion, recurrent respiratory tract infection; ? Severe malnutrition, rickets children and complicated with heart, brain, liver, kidney and hematopoietic system serious primary diseases; ? to test drug allergy or allergic constitution (to two or more food or drug allergy); ? Other lesions or conditions that reduce the possibility of enrollment or complicate enrollment, such as unstable living environment, inconvenient transportation and other conditions that may easily lead to loss of follow-up, according to the judgment of the investigator.

发起方

Beijing University of Chinese Medicine